Inozyme Pharma Inc Financial Flexibility Index
Inozyme Pharma Inc financial flexibility index. Inozyme Pharma Inc (INZY) has a Financial Flexibility Index of -0.46x as of March 2025. Free cash flow of $-29.15 Million (operating CF $-29.15 Million minus capex $0.00) represents 0% of total liabilities ($63.37 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Inozyme Pharma Inc (2018–2024)
Financial flexibility index of Inozyme Pharma Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Inozyme Pharma Inc across 7 annual periods. Explore Inozyme Pharma Inc (INZY) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Inozyme Pharma Inc Financial Flexibility Index by Year (2018–2024)
Inozyme Pharma Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Inozyme Pharma Inc. For the full cash flow conversion analysis, see cash flow conversion of Inozyme Pharma Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.41x | $-91.84 Million | $-91.91 Million | $65.36 Million | ▼ -20.5% |
| 2023 | -1.17x | $-70.38 Million | $-70.67 Million | $60.37 Million | ▲ +57.7% |
| 2022 | -2.76x | $-57.35 Million | $-57.76 Million | $20.80 Million | ▲ +17.6% |
| 2021 | -3.35x | $-47.76 Million | $-48.15 Million | $14.27 Million | ▼ -6.4% |
| 2020 | -3.14x | $-35.41 Million | $-35.97 Million | $11.26 Million | ▼ -1266.9% |
| 2019 | -0.23x | $-18.67 Million | $-18.81 Million | $81.16 Million | ▼ -43.9% |
| 2018 | -0.16x | $-9.18 Million | $-9.44 Million | $57.42 Million | — |